Vailoces, Jovit .

HRN: 24-48-29  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/05/2024
02/11/2024
IV
2.25g
Q8
DM Foot
Waiting Final Action 
02/06/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/06/2024
02/13/2024
IV
600mg
Q8hrs
DM FOOT
Waiting Final Action 
02/06/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/06/2024
02/13/2024
IV
1.5g
Q12
DM Foot; CKD
Waiting Final Action 
02/08/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/08/2024
02/16/2024
IV
2.25gm
TID
Infected Woundf
Waiting Final Action 
02/08/2024
AZITHROMYCIN 500MG TABLET (TAB)
02/08/2024
02/12/2024
PO
500mgtab
Q24
Cap Mr
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: